318 related articles for article (PubMed ID: 16037946)
1. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women.
Kunde SS; Lazenby AJ; Clements RH; Abrams GA
Hepatology; 2005 Sep; 42(3):650-6. PubMed ID: 16037946
[TBL] [Abstract][Full Text] [Related]
2. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
Abrams GA; Kunde SS; Lazenby AJ; Clements RH
Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and histological features of non-alcoholic fatty liver disease].
Shi JP; Xun YH; Hu CB; Zhang L; Liu H; Lou GQ; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):812-6. PubMed ID: 19958638
[TBL] [Abstract][Full Text] [Related]
4. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
6. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
Ito S; Yukawa T; Uetake S; Yamauchi M
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
[TBL] [Abstract][Full Text] [Related]
8. Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance.
de Luis DA; Aller R; Izaola O; Sagrado MG; Conde R; Gonzalez JM
Diabetes Res Clin Pract; 2008 Jan; 79(1):74-8. PubMed ID: 17766001
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
10. Aminotransferase activity in morbid and uncomplicated obesity: predictive role of fasting insulin.
Iacobellis G; Moschetta A; Buzzetti R; Ribaudo MC; Baroni MG; Leonetti F
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):442-7. PubMed ID: 17134955
[TBL] [Abstract][Full Text] [Related]
11. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
Sorbi D; Boynton J; Lindor KD
Am J Gastroenterol; 1999 Apr; 94(4):1018-22. PubMed ID: 10201476
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women.
Prati D; Colli A; Conte D; Colombo M
Hepatology; 2005 Dec; 42(6):1460-1; author reply 1461. PubMed ID: 16317678
[No Abstract] [Full Text] [Related]
13. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis.
Sreenivasa Baba C; Alexander G; Kalyani B; Pandey R; Rastogi S; Pandey A; Choudhuri G
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):191-8. PubMed ID: 16706832
[TBL] [Abstract][Full Text] [Related]
14. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
[TBL] [Abstract][Full Text] [Related]
15. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
[TBL] [Abstract][Full Text] [Related]
17. Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?
Canbakan B; Senturk H; Canbakan M; Toptas T; Tabak O; Balci H; Olgac V; Ozbay G
Biomark Med; 2010 Apr; 4(2):205-14. PubMed ID: 20406065
[TBL] [Abstract][Full Text] [Related]
18. Association between elevated serum hepatic enzyme activity and total body fat in obese humans.
Choi JW
Ann Clin Lab Sci; 2003; 33(3):257-64. PubMed ID: 12956439
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum and natural history of non-alcoholic steatohepatitis with normal alanine aminotransferase values.
Amarapurkar DN; Patel ND
Trop Gastroenterol; 2004; 25(3):130-4. PubMed ID: 15682660
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
